[1]
|
Lizneva, D., Suturina, L., Walker, W., et al. (2016) Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 6-15. https://doi.org/10.1016/j.fertnstert.2016.05.003
|
[2]
|
Fauser, B.C., Tarlatzis, B.C., Rebar, R.W., et al. (2012) Consensus on Women’s Health Aspects of Polycystic Ovary Syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility, 97, 28-38. https://doi.org/10.1016/j.fertnstert.2011.09.024
|
[3]
|
Mills, G., Badeghiesh, A., Suarthana, E., et al. (2020) Polycystic Ovary Syndrome as an Independent Risk Factor for Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Population-Based Study on 9.1 Million Pregnancies. Human Reproduction, 35, 1666-1674. https://doi.org/10.1093/humrep/deaa099
|
[4]
|
Cooney, L.G. and Dokras, A. (2018) Beyond Fertility: Polycystic Ovary Syndrome and Long-Term Health. Fertility and Sterility, 110, 794-809. https://doi.org/10.1016/j.fertnstert.2018.08.021
|
[5]
|
(2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Fertility and Sterility, 81, 19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004
|
[6]
|
Azziz, R. (2016) PCOS in 2015: New Insights into the Genetics of Polycystic Ovary Syndrome. Nature Reviews Endocrinology, 12, 74-75. https://doi.org/10.1038/nrendo.2015.230
|
[7]
|
Azziz, R. (2018) Polycystic Ovary Syndrome. Obstetrics & Gynecology, 132, 321-336.
https://doi.org/10.1097/AOG.0000000000002698
|
[8]
|
Blank, S.K., McCartney, C.R. and Marshall, J.C. (2006) The Origins and Sequelae of Abnormal Neuroendocrine Function in Polycystic Ovary Syndrome. Human Reproduction Update, 12, 351-361.
https://doi.org/10.1093/humupd/dml017
|
[9]
|
Stubbs, S.A., Hardy, K., Da, S.P., et al. (2005) Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries. The Journal of Clinical Endocrinology & Metabolism, 90, 5536-5543. https://doi.org/10.1210/jc.2005-0907
|
[10]
|
Fauser, B.C. and Van Heusden, A.M. (1997) Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences. Endocrine Reviews, 18, 71-106. https://doi.org/10.1210/edrv.18.1.0290
|
[11]
|
Hsieh, M., Thao, K. and Conti, M. (2011) Genetic Dissection of Epidermal Growth Factor Receptor Signaling during Luteinizing Hormone-Induced Oocyte Maturation. PLoS ONE, 6, e21574.
https://doi.org/10.1371/journal.pone.0021574
|
[12]
|
Valkenburg, O., Uitterlinden, A.G., Piersma, D., et al. (2009) Genetic Polymorphisms of GnRH and Gonadotrophic Hormone Receptors Affect the Phenotype of Polycystic Ovary Syndrome. Human Reproduction, 24, 2014-2022.
https://doi.org/10.1093/humrep/dep113
|
[13]
|
Rosenfield, R.L. and Ehrmann, D.A. (2016) The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews, 37, 467-520.
https://doi.org/10.1210/er.2015-1104
|
[14]
|
Li, T., Mo, H., Chen, W., et al. (2017) Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome. Reproductive Sciences, 24, 646-655. https://doi.org/10.1177/1933719116667606
|
[15]
|
Webber, L.J., Stubbs, S., Stark, J., et al. (2003) Formation and Early Development of Follicles in the Polycystic Ovary. The Lancet, 362, 1017-1021. https://doi.org/10.1016/S0140-6736(03)14410-8
|
[16]
|
Zeng, X., Xie, Y.J., Liu, Y.T., et al. (2020) Polycystic Ovarian Syndrome: Correlation between Hyperandrogenism, Insulin Resistance and Obesity. Clinica Chimica Acta, 502, 214-221. https://doi.org/10.1016/j.cca.2019.11.003
|
[17]
|
Kraemer, W.J., Ratamess, N.A., Hymer, W.C., et al. (2020) Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth with Exercise. Frontiers in Endocrinology (Lausanne), 11, 33. https://doi.org/10.3389/fendo.2020.00033
|
[18]
|
Dunaif, A. (1997) Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis. Endocrine Reviews, 18, 774-800. https://doi.org/10.1210/er.18.6.774
|
[19]
|
Lan, C.W., Chen, M.J., Tai, K.Y., et al. (2015) Functional Microarray Analysis of Differentially Expressed Genes in Granulosa Cells from Women with Polycystic Ovary Syndrome Related to MAPK/ERK Signaling. Scientific Reports, 5, Article No. 14994. https://doi.org/10.1038/srep14994
|
[20]
|
Chen, M.J., Chou, C.H., Chen, S.U., et al. (2015) The Effect of Androgens on Ovarian Follicle Maturation: Dihydrotestosterone Suppress FSH-Stimulated Granulosa Cell Proliferation by Upregulating PPARgamma-Dependent PTEN Expression. Scientific Reports, 5, Article No. 18319. https://doi.org/10.1038/srep18319
|
[21]
|
Liu, H., Luo, L.L., Qian, Y.S., et al. (2009) FOXO3a Is Involved in the Apoptosis of Naked Oocytes and Oocytes of Primordial Follicles from Neonatal Rat Ovaries. Biochemical and Biophysical Research Communications, 381, 722-727.
https://doi.org/10.1016/j.bbrc.2009.02.138
|
[22]
|
Salehi, R., Mazier, H.L., Nivet, A.L., et al. (2020) Ovarian Mitochondrial Dynamics and Cell Fate Regulation in an Androgen-Induced Rat Model of Polycystic Ovarian Syndrome. Scientific Reports, 10, Article No. 1021.
https://doi.org/10.1038/s41598-020-57672-w
|
[23]
|
Jin, J., Ma, Y., Tong, X., et al. (2020) Metformin Inhibits Testosterone-Induced Endoplasmic Reticulum Stress in Ovarian Granulosa Cells via Inactivation of p38 MAPK. Human Reproduction, 35, 1145-1158.
https://doi.org/10.1093/humrep/deaa077
|
[24]
|
Salley, K.E., Wickham, E.P., Cheang, K.I., et al. (2007) Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society. The Journal of Clinical Endocrinology & Metabolism, 92, 4546-4556.
https://doi.org/10.1210/jc.2007-1549
|
[25]
|
Cassar, S., Misso, M.L., Hopkins, W.G., et al. (2016) Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic-Hyperinsulinaemic Clamp Studies. Human Reproduction, 31, 2619-2631.
https://doi.org/10.1093/humrep/dew243
|
[26]
|
Hansen, S.L., Svendsen, P.F., Jeppesen, J.F., et al. (2019) Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 104, 1841-1854. https://doi.org/10.1210/jc.2018-01771
|
[27]
|
Diamanti-Kandarakis, E. and Dunaif, A. (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews, 33, 981-1030. https://doi.org/10.1210/er.2011-1034
|
[28]
|
Tosi, F., Dal Molin, F., Zamboni, F., et al. (2020) Serum Androgens Are Independent Predictors of Insulin Clearance but Not of Insulin Secretion in Women with PCOS. The Journal of Clinical Endocrinology & Metabolism, 105, dgaa095.
https://doi.org/10.1210/clinem/dgaa095
|
[29]
|
Kelly, C.C., Lyall, H., Petrie, J.R., et al. (2001) Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism, 86, 2453-2455.
https://doi.org/10.1210/jcem.86.6.7580
|
[30]
|
Vgontzas, A.N., Trakada, G., Bixler, E.O., et al. (2006) Plasma Interleukin 6 Levels Are Elevated in Polycystic Ovary Syndrome Independently of Obesity or Sleep Apnea. Metabolism, 55, 1076-1082.
https://doi.org/10.1016/j.metabol.2006.04.002
|
[31]
|
Gonzalez, F., Rote, N.S., Minium, J., et al. (2006) In Vitro Evidence That Hyperglycemia Stimulates Tumor Necrosis Factor-Alpha Release in Obese Women with Polycystic Ovary Syndrome. Journal of Endocrinology, 188, 521-529.
https://doi.org/10.1677/joe.1.06579
|
[32]
|
Li, S., Zhao, L. and Wan, X.H. (2017) A Missense Variant rs4645843 in TNF-alpha Gene Is a Risk Factor of Polycystic Ovary Syndrome in the Uygur Population. The Tohoku Journal of Experimental Medicine, 243, 95-100.
https://doi.org/10.1620/tjem.243.95
|
[33]
|
Liu, R., Zhang, C., Shi, Y., et al. (2017) Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. Frontiers in Microbiology, 8, 324. https://doi.org/10.3389/fmicb.2017.00324
|
[34]
|
Egshatyan, L., Kashtanova, D., Popenko, A., et al. (2016) Gut Microbiota and Diet in Patients with Different Glucose Tolerance. Endocrine Connections, 5, 1-9. https://doi.org/10.1530/EC-15-0094
|
[35]
|
Cani, P.D., Amar, J., Iglesias, M.A., et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes, 56, 1761-1772. https://doi.org/10.2337/db06-1491
|
[36]
|
Qi, X., Yun, C., Sun, L., et al. (2019) Gut Microbiota-Bile Acid-Interleukin-22 Axis Orchestrates Polycystic Ovary Syndrome. Nature Medicine, 25, 1225-1233. https://doi.org/10.1038/s41591-019-0509-0
|
[37]
|
Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G., et al. (2011) Polycystic Ovary Syndrome: Etiology, Pathogenesis and Diagnosis. Nature Reviews Endocrinology, 7, 219-231. https://doi.org/10.1038/nrendo.2010.217
|
[38]
|
Mykhalchenko, K., Lizneva, D., Trofimova, T., et al. (2017) Genetics of Polycystic Ovary Syndrome. Expert Reviews Molecular Diagnostics, 17, 723-733. https://doi.org/10.1080/14737159.2017.1340833
|
[39]
|
Cui, L., Zhao, H., Zhang, B., et al. (2013) Genotype-Phenotype Correlations of PCOS Susceptibility SNPs Identified by GWAS in a Large Cohort of Han Chinese Women. Human Reproduction (Oxford), 28, 538-544.
https://doi.org/10.1093/humrep/des424
|
[40]
|
Langley-Evans, S.C., Bellinger, L. and McMullen, S. (2005) Animal Models of Programming: Early Life Influences on Appetite and Feeding Behaviour. Maternal & Child Nutrition, 1, 142-148.
https://doi.org/10.1111/j.1740-8709.2005.00015.x
|
[41]
|
Martin-Gronert, M.S. and Ozanne, S.E. (2005) Programming of Appetite and Type 2 Diabetes. Early Human Development, 81, 981-988. https://doi.org/10.1016/j.earlhumdev.2005.10.006
|
[42]
|
Homburg, R., Gudi, A., Shah, A., et al. (2017) A Novel Method to Demonstrate That Pregnant Women with Polycystic Ovary Syndrome Hyper-Expose Their Fetus to Androgens as a Possible Stepping Stone for the Developmental Theory of PCOS. A Pilot Study. Reproductive Biology and Endocrinology, 15, 61. https://doi.org/10.1186/s12958-017-0282-1
|
[43]
|
Raperport, C. and Homburg, R. (2019) The Source of Polycystic Ovarian Syndrome. Clinical Medicine Insights: Reproductive Health, 13, Article ID: 1186599915. https://doi.org/10.1177/1179558119871467
|
[44]
|
Cheng, M.Y., Bullock, C.M., Li, C., et al. (2002) Prokineticin 2 Transmits the Behavioural Circadian Rhythm of the Suprachiasmatic Nucleus. Nature, 417, 405-410. https://doi.org/10.1038/417405a
|
[45]
|
Wang, W., Yin, L., Bai, L., et al. (2017) Bmal1 Interference Impairs Hormone Synthesis and Promotes Apoptosis in Porcine Granulosa Cells. Theriogenology, 99, 63-68. https://doi.org/10.1016/j.theriogenology.2017.05.010
|
[46]
|
Sharma, A., Laurenti, M.C., Dalla, M.C., et al. (2017) Glucose Metabolism during Rotational Shift-Work in Healthcare Workers. Diabetologia, 60, 1483-1490. https://doi.org/10.1007/s00125-017-4317-0
|
[47]
|
Simon, S.L., McWhirter, L., Diniz, B.C., et al. (2019) Morning Circadian Misalignment Is Associated with Insulin Resistance in Girls with Obesity and Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism, 104, 3525-3534. https://doi.org/10.1210/jc.2018-02385
|